Stay updated with breaking news from Express Scripts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The New York Times is looking into pharmacy benefit managers, which play crucial roles in determining which medications your insurance covers and how much you pay.
Eli Lilly CEO David Ricks on Monday said the company's powerful weight-loss drug Zepbound hit 25,000 new prescriptions per week at the end of December, and that its 2024 supply may not be enough to meet demand. "I think it's important to set expectations, but we're working hard to fulfill demand," he told Reuters at the annual JPMorgan health conference in San Francisco. Ricks declined to provide details on how much Zepbound Lilly can produce now, or to forecast 2024 demand and eventual supply.
Prescription drugs that Americans need for better health could be in closer financial reach. Applaud needed amendments to the country’s overpriced pharmaceutical system.
Stock was down about 2% in pre-market trading on the news that the company is cutting its dividend by 48% to 25 cents a share, from 48 cents a share, for the…
Health insurer Cigna Group is in exclusive talks to sell its Medicare Advantage business to Health Care Service Corp for between $3 billion and $4 billion, a source familiar with the matter said on...